Recce PharmaceuticalsRCE 
$0.29-7.07%24h
-7.07%24h
Global rank23012
Market cap$50.15M
Change 7d-8.00%
YTD Performance-13.21%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings-$8.11M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Recce Pharmaceuticals (RCE)
Recce Pharmaceuticals has an EPS of $-0.062477. In 2021, the company made an earnings per share (EPS) of $-0.086141. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for RCE
-
Value:-
EPS history for Recce Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | -$0.062477 | -27.47% |
| 2021 | -$0.086141 | 156.64% |
| 2020 | -$0.033565 | - |
View the highest EPS stocks
